Full Text View
Tabular View
Study Results
Related Studies
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) (GALILEO)
This study has been completed.
Study NCT01012973   Information provided by Bayer

First Received on October 30, 2009.   Last Updated on January 18, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Retinal Vein Occlusion
Additional conditions recognized in this trial
Macular Edema
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Eye Diseases
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Thrombosis
Vascular Diseases
Venous Thrombosis
Interventions listed in this trial
Sham treatment
Additional drug interventions recognized in this trial
Endothelial Growth Factors
More general drug interventions related to this trial
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Bayer
Regeneron Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services